Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (311-320 of 737) with videos related to

Pageof 74
Sort By:
Scientific Reports|November 3, 2024
Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumabTomohiro Hosoya, Atsushi Kambe, Irfan Kesumayadi, et al.
ACS Medicinal Chemistry Letters|May 15, 2024
Simple Fluorescence Labeling Method Enables Detection of Intracellular Distribution and Expression Level of Retinoid X ReceptorsYukina Tanaka, Michiko Fujihara, Yuta Takamura, et al.
Yonago Acta Medica|February 19, 2024
Efficacy of Subtraction Computed Tomography Arteriography During Preoperative Embolization in Spinal TumorsJun Makishima, Shuichi Yamamoto, Shinsaku Yata, et al.
Viruses|February 24, 2024
The Importance of Lassa Fever and Its Disease Management in West AfricaRachel A Reyna, Kirsten E Littlefield, Nathan Shehu, et al.
Scientific Reports|July 31, 2023
ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1Sayuri Takahashi, Ichiro Takada, Kenichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|September 14, 2016
Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonistsShogo Okazaki, Ryuta Shioi, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2017
Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonistsRyuta Shioi, Shogo Okazaki, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2010
LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivatorsYusuke Mita, Kosuke Dodo, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2008
Improvement of the transactivation activity of phenylpropanoic acid-type peroxisome proliferator-activated receptor pan agonists: effect of introduction of fluorine at the linker partJun-ichi Kasuga, Takuji Oyama, Yuko Hirakawa, et al.
Toxicology and Applied Pharmacology|March 17, 2009
CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell linesShigeyuki Uno, Kaori Endo, Yuji Ishida, et al.
Pageof 74

Showing results (311-320 of 737) with videos related to

Sort By:
Pageof 74
Scientific Reports|November 3, 2024
Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumabTomohiro Hosoya, Atsushi Kambe, Irfan Kesumayadi, et al.
ACS Medicinal Chemistry Letters|May 15, 2024
Simple Fluorescence Labeling Method Enables Detection of Intracellular Distribution and Expression Level of Retinoid X ReceptorsYukina Tanaka, Michiko Fujihara, Yuta Takamura, et al.
Yonago Acta Medica|February 19, 2024
Efficacy of Subtraction Computed Tomography Arteriography During Preoperative Embolization in Spinal TumorsJun Makishima, Shuichi Yamamoto, Shinsaku Yata, et al.
Viruses|February 24, 2024
The Importance of Lassa Fever and Its Disease Management in West AfricaRachel A Reyna, Kirsten E Littlefield, Nathan Shehu, et al.
Scientific Reports|July 31, 2023
ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1Sayuri Takahashi, Ichiro Takada, Kenichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry|September 14, 2016
Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonistsShogo Okazaki, Ryuta Shioi, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2017
Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonistsRyuta Shioi, Shogo Okazaki, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2010
LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivatorsYusuke Mita, Kosuke Dodo, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2008
Improvement of the transactivation activity of phenylpropanoic acid-type peroxisome proliferator-activated receptor pan agonists: effect of introduction of fluorine at the linker partJun-ichi Kasuga, Takuji Oyama, Yuko Hirakawa, et al.
Toxicology and Applied Pharmacology|March 17, 2009
CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell linesShigeyuki Uno, Kaori Endo, Yuji Ishida, et al.
Pageof 74